The intraoperative use of Amicar to reduce bleeding associated with open heart surgery.

Abstract

In an effort to reduce morbidity associated with transfusion of blood products, Amicar is used as a prophylactic inhibitor of hyperfibrinolysis associated with diffuse perioperative bleeding in patients undergoing open heart surgery. Previous studies indicate a significant reduction of intraoperative and postoperative bleeding in patients receiving Amicar during open heart surgery. Fifteen historical controls who did not receive Amicar were compared to 15 nonrandomized, prospective patients who received Amicar and who underwent open heart surgery by the same surgeon. The study found a significant reduction in postoperative chest tube output for the group receiving Amicar, as well as a reduction in perioperative blood product transfusion in patients who received Amicar. One patient in the Amicar group experienced a thrombotic event.

• Authors: A E Aprile, T J Palmer
• Journal: AANA journal (AANA J) Vol. 63 Issue 4 Pg. 325-31 (Aug 1995) ISSN: 0094-6354 [Print] United States
• PMID: 7676769 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)

Chemical References

• Aminocaproic Acid

Topics

• Aged
• Aminocaproic Acid (therapeutic use)
• Blood Loss, Surgical
• Blood Transfusion
• Cardiac Surgical Procedures (adverse effects)
• Chest Tubes
• Female
• Humans
• Intraoperative Care
• Male
• Middle Aged
• Prospective Studies